| Financial Year |
March 31 2023 |
| Monetary Funds |
211,834,720.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
210,835,333.60 |
| Accounts Receivable |
604,636,146.42 |
| Advances to Suppliers |
22,144,258.12 |
| Other Receivables |
27,283,753.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
202,989,061.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,819,980.92 |
| Other Current Assets |
13,798,050.77 |
| Total Current Assets |
1,800,801,102.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,236,721.35 |
| Long-term Equity Investment |
69,914,276.12 |
| Investment Properties |
152,514,605.60 |
| Fixed Assetes |
443,105,320.43 |
| Under-construction Projects |
144,398,305.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
134,168,260.73 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,820,906.29 |
| Deferred Income Tax Assets |
29,984,299.43 |
| Other Non-Current Assets |
35,985,762.81 |
| Sub-Total of Non-Current Assets |
1,161,343,854.28 |
| Total Assets |
2,962,144,957.05 |
| Short-Term Loans |
653,320,239.59 |
| Trading Financial liabilities |
-- |
| Notes Payable |
62,709,372.00 |
| Accounts Payable |
305,228,745.18 |
| Accounts Received In Advance |
1,030,055.82 |
| Employee Compensation Payable |
30,521,773.25 |
| Taxes Payable |
18,229,498.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
165,395,966.38 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,108,514.86 |
| Other Current Liabilities |
8,903,319.44 |
| Sub-Total of Current Liabilities |
1,265,105,350.18 |
| Long-term Loans |
30,011,305.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
46,248,990.67 |
| Deferred Income Tax Liabilities |
17,398,584.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
199,228,165.08 |
| Total Liabilities |
1,464,333,515.26 |
| Paid-In Capital(Or Share Stock) |
1,136,400,000.00 |
| Capital Surplus |
491,951,141.38 |
| Surplus Reserve |
34,558,636.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-182,156,446.02 |
| Minority Stockholder's Interest |
-6,364,044.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,504,175,486.69 |
| Owner's Equity（Stockholder's Equity） |
1,497,811,441.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,962,144,957.05 |
